|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3458478 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17726862.0 |
| Date of filing the European patent application | 2017-05-17 | |
| (97) | Date of publication of the European application | 2019-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation | 2021-02-10 |
| (86) | Number | PCT/EP2017/061901 |
| Date | 2017-05-17 |
| (87) | Number | WO 2017/198741 |
| Date | 2017-11-23 |
| (30) | Number | Date | Country code |
| 16170174 | 2016-05-18 | EP |
| (72) |
ZETTL, Markus, DE
LORENZ, Ivo, US
SCHAAF, Otmar, DE
WURM, Melanie, DE
FORTIN, Jean-Franēois, CA
BRODEUR, Scott, US
CANADA, Keith A., US
CHLEWICKI, Lukasz, US
GUPTA, Pankaj, US
GUPTA, Priyanka, US
PEREZ, Rocio K., US
WOSKA Jr., Joseph Robert, US
XIAO, Haiguang, US
YANG, Danlin, US
DAVIDSON, Walter Carroll, US
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš PD-1 ir LAG-3, skirti vėžio gydymui |
| ANTI PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2025-04-24 | 9 | 208.00 EUR |
| 2026-05-17 |